TC-N19, a novel dual inhibitor of EGFR and cMET, efficiently overcomes EGFR-TKI resistance in non-small-cell lung cancer cells
Crossref DOI link: https://doi.org/10.1038/cddis.2016.192
Published Online: 2016-06-30
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wu, D-W
Chen, T-C
Huang, H-S
Lee, H
Text and Data Mining valid from 2016-06-30
Version of Record valid from 2016-06-30
Article History
Received: 11 April 2016
Revised: 3 June 2016
Accepted: 6 June 2016
First Online: 30 June 2016
Competing interests
: The authors declare no conflict of interest.